Tabla de Contenidos: “…Endocrine and Neural Bases of Fear: Implications for Understanding Extreme Shyness and Developmental Outcome; 6 Neural Mechanisms and the Development of Individual Differences in Behavioral Inhibition; 7 The Neural Circuits that Underlie Fear; 8 Neuroendocrine Regulation of Fear and Anxiety; 9 Lifelong Effects of Hormones on Brain Development: Relationship to Health and Disease; Commentary: The Inhibited Child ""Syndrome"": Thoughts on its Potential Pathogenesis and Sequelae; Part III. …”

“…A better understanding of these mechanisms allows the search for biomarkers and targets for new therapies. …”

Tabla de Contenidos: “…Volumen: I, Materials Physics - Materials Mechanics. -- Volumen: II, Physics Design - Reliability and Packaging…”

Tabla de Contenidos: “…Front Cover -- Medicines for Cancer -- Medicines for Cancer: MECHANISM OF ACTION AND CLINICAL PHARMACOLOGY OF CHEMO, HORMONAL, TARGETED, AND IMMUNOTHERAPIES -- Copyright -- Medical advice disclaimer -- Contents -- About the author -- Preface -- Common abbreviations and acronyms -- 1 - Drug nomenclature -- 1.1 Generic formula -- References -- 2 - Chemotherapy -- 2.1 Alkylating antineoplastic agents -- 2.2 Nitrosoureas -- 2.3 Antimetabolites -- 2.4 Antitumor antibiotics -- 2.4.1 Anthracyclines -- 2.4.2 Nonanthracyclines -- 2.5 Topoisomerase inhibitors -- 2.6 Mitotic inhibitors (antimicrotubule agents) -- 2.7 Corticosteroids -- 2.8 Other chemotherapy drugs -- 2.9 US FDA-approved current chemotherapy agents -- 2.10 Albumin-bound paclitaxel -- 2.10.1 Indications (medical uses) -- 2.10.2 Metastatic breast cancer -- 2.10.3 Dosage and administration -- 2.10.4 Mechanism of action -- 2.10.5 Pharmacokinetics -- 2.10.6 Side effects -- 2.11 Amifostine -- 2.11.1 Indications (medical uses) -- 2.11.2 Dosage and administration -- 2.11.3 Mechanism of action -- 2.11.4 Pharmacokinetics -- 2.11.5 Side effects -- 2.12 Arsenic trioxide -- 2.12.1 Indications (medical uses) -- 2.12.2 Dosage and administration -- 2.12.3 Mechanism of action -- 2.12.4 Pharmacokinetics -- 2.12.5 Side effects -- 2.13 Asparaginase Erwinia chrysanthemi -- 2.13.1 Indications (medical uses) -- 2.13.2 Dosage and administration -- 2.13.3 Mechanism of action -- 2.13.4 Pharmacokinetics -- 2.13.5 Side effects -- 2.14 Azacitidine -- 2.14.1 Indications (medical uses) -- 2.14.2 Dosage and administration -- 2.14.3 Mechanism of action -- 2.14.4 Pharmacokinetics -- 2.14.5 Side effects -- 2.15 Bendamustine -- 2.15.1 Indications (medical uses) -- 2.15.2 Dosage and administration -- 2.15.3 Mechanism of action -- 2.15.4 Pharmacokinetics -- 2.15.5 Side effects -- 2.16 Bleomycin…”

Materias:

“…This work approaches the fields of homogenization and of materials design for the linear and nonlinear mechanical properties with prescribed properties-profile. …”

“…Pathogenetic Mechanisms at the Basis of Aortopathy Associated with Bicuspid Aortic Valve…”